MEA家禽用プロバイオティクス原料市場-2030年までの産業動向と予測MEA Poultry Probiotic Ingredients Market - Industry Trends and Forecast to 2030 中東・アフリカの家禽用プロバイオティクス原料市場は、2022年の61,730.85千米ドルから2030年には88,346.43千米ドルに達し、2023年から2030年の予測期間中に年平均成長率4.7%で成長すると予想される。 市場細... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー中東・アフリカの家禽用プロバイオティクス原料市場は、2022年の61,730.85千米ドルから2030年には88,346.43千米ドルに達し、2023年から2030年の予測期間中に年平均成長率4.7%で成長すると予想される。市場細分化: 中東・アフリカの家禽用プロバイオティクス成分市場:製品別(細菌ベース、真菌・酵母ベース)、タイプ別(単一株、複数株)、形態別(乾燥、液体)、機能別(飼料摂取量と効率、歩留まり、腸の健康、栄養、卵生産と品質免疫、その他)、用途(ブロイラー、レイヤー、ブリーダー、ヒヨコとパウロ、その他)、国(南アフリカ、サウジアラビア、アラブ首長国連邦、クウェート、中東・アフリカのその他) - 産業動向と2030年までの予測 中東およびアフリカの家禽用プロバイオティクス原料市場の動向:概要 促進要因 - 植物由来製品の利点に対する認識の高まり 抑制 - 原料の供給不足 機会 - 鶏肉製品におけるプロバイオティクスの商業的応用の拡大 市場プレーヤー 中東・アフリカの家禽用プロバイオティクス原料市場で事業を展開する主な市場プレーヤーは以下の通りである: - ラレマンド社 - オールテック - バイオキャンプ - インターナショナル・アニマル・ヘルス・プロダクツ - ユニークバイオテック - プロビタアニマルヘルス - フィレオ バイ レザフレ - ノボザイムズ - エボニック - アサヒグループホールディングス - クリスチャン・ハンセン・ホールディングA/S - アドバンスド・エンザイム・テクノロジーズ - インターナショナル・フレーバー&フレグランス社 - ケミン・インダストリーズ - パングー 目次TABLE OF CONTENTS1 INTRODUCTION 42 1.1 OBJECTIVES OF THE STUDY 42 1.2 MARKET DEFINITION 42 1.3 OVERVIEW OF MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET 42 1.4 LIMITATIONS 44 1.5 MARKETS COVERED 44 2 MARKET SEGMENTATION 47 2.1 MARKETS COVERED 47 2.2 GEOGRAPHICAL SCOPE 48 2.3 YEARS CONSIDERED FOR THE STUDY 49 2.4 CURRENCY AND PRICING 49 2.5 DBMR TRIPOD DATA VALIDATION MODEL 50 2.6 MULTIVARIATE MODELLING 53 2.7 PRODUCT LIFELINE CURVE 53 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 54 2.9 DBMR MARKET POSITION GRID 55 2.10 MARKET END USERS COVERAGE GRID 56 2.11 VENDOR SHARE ANALYSIS 57 2.12 SECONDARY SOURCES 58 2.13 ASSUMPTIONS 58 3 EXECUTIVE SUMMARY 59 4 PREMIUM INSIGHTS 61 4.1 VALUE CHAIN ANALYSIS 62 4.2 SUPPLY CHAIN ANALYSIS 63 4.2.1 RAW MATERIAL PROCUREMENT 63 4.2.2 MANUFACTURING AND DISTRIBUTION 63 4.2.3 END USERS 63 4.3 PORTER'S FIVE FORCES 64 4.3.1 BARGAINING POWER OF SUPPLIERS 64 4.3.2 BARGAINING POWER OF BUYERS/CONSUMERS 64 4.3.3 THREAT OF NEW ENTRANTS 65 4.3.4 THREAT OF SUBSTITUTES PRODUCTS 65 4.3.5 INTENSITY OF COMPETITIVE RIVALRY 65 4.4 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 66 4.5 OVERVIEW OF TECHNOLOGICAL INNOVATIONS 67 4.6 INDUSTRY TRENDS AND FUTURE PERSPECTIVE 68 4.7 FACTORS INFLUENCING PURCHASING DECISION OF END-USERS 69 5 PRICING ANALYSIS 70 6 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, REGULATIONS 71 7 MARKET OVERVIEW, MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET 73 7.1 DRIVERS 75 7.1.1 GROWING PRODUCTION OF FEED ADDITIVES 75 7.1.2 INCREASING AWARENESS OF THE BENEFITS OF PLANT-BASED PRODUCTS 75 7.1.3 INCREASED DEMAND AND CONSUMPTION OF LIVESTOCK-BASED PRODUCTS 76 7.2 RESTRAINTS 76 7.2.1 STRICT RESTRICTIONS AND REGULATIONS IMPOSED BY GOVERNMENT 76 7.2.2 INADEQUATE RAW MATERIAL AVAILABILITY 77 7.3 OPPORTUNITIES 77 7.3.1 GROWING COMMERCIAL APPLICATION 77 7.3.2 RISING RESEARCH AND DEVELOPMENT ACTIVITIES 77 7.4 CHALLENGES 78 7.4.1 AVAILABILITY OF FEED ADDITIVE SUBSTITUTES 78 7.4.2 PRODUCT LABELLING AND TRADE ISSUES 78 8 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY PRODUCT 79 8.1 OVERVIEW 80 8.1.1 BACTERIA BASED 83 8.1.1.1 BACILLUS 84 8.1.1.1.1 SUBTILIS 85 8.1.1.1.2 LICHENIFORMIS 85 8.1.1.1.3 AMYLOLIQUEFACIENS 85 8.1.1.1.4 MEGATERIUM 85 8.1.1.1.5 MESENTRICUS 85 8.1.1.1.6 POLYMYXA 85 8.1.1.1.7 TOYONENSIS 85 8.1.1.1.8 OTHERS 85 8.1.1.2 LACTOBACILLUS 86 8.1.1.2.1 ACIDOPHILUS 86 8.1.1.2.2 BULGARICUS 86 8.1.1.2.3 REUTERI 86 8.1.1.2.4 CASEI 87 8.1.1.2.5 LACTIS 87 8.1.1.2.6 SALIVARIUS 87 8.1.1.2.7 PLANTARUM 87 8.1.1.2.8 RHAMNOSUS 87 8.1.1.2.9 FERMENTUM 87 8.1.1.2.10 FARCIMINIS 87 8.1.1.2.11 THERMOPHILUS 87 8.1.1.2.12 OTHERS 88 8.1.1.3 BIFIDOBACTERIUM 88 8.1.1.3.1 BIFIDIUM 88 8.1.1.3.2 BIFIDUS 88 8.1.1.3.3 THERMOPHILUS 88 8.1.1.3.4 ANIMALS 88 8.1.1.3.5 OTHERS 89 8.1.1.4 ENTEROCOCCUS 89 8.1.1.5 STREPTOCOCCUS 89 8.1.1.6 CLOSTRIDIUM 89 8.1.1.7 PEDIOCOCCUS 89 8.1.1.7.1 PARVULUS 89 8.1.1.7.2 ACIDILACTICI 89 8.1.1.7.3 OTHERS 90 8.1.2 FUNGI AND YEAST BASED 90 8.1.2.1 SACCHAROMYCES CEREVISIAE 91 8.1.2.2 SACCHAROMYCES BOULARDII 91 8.1.2.3 SACCHAROMYCES SERVISIA 91 8.1.2.4 CANDIDA 91 9 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY TYPE 92 9.1 OVERVIEW 93 9.1.1 SINGLE STRAIN 96 9.1.2 MULTIPLE STRAIN 96 10 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY FORM 98 10.1 OVERVIEW 99 10.1.1 DRY 102 10.1.2 LIQUID 102 11 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY FUNCTION 104 11.1 OVERVIEW 105 11.1.1 GUT HEALTH 108 11.1.2 IMMUNITY 108 11.1.3 NUTRITION 109 11.1.4 FEED INTAKE AND EFFICIENCY 110 11.1.5 YIELD 110 11.1.6 EGG PRODUCTION AND QUALITY 111 11.1.7 OTHERS 112 12 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY APPLICATION 113 12.1 OVERVIEW 114 12.1.1 CHICKS AND POULTS 117 12.1.1.1 BACTERIA BASED 118 12.1.1.2 FUNGI AND YEAST BASED 118 12.1.2 BROILERS 118 12.1.2.1 BACTERIA BASED 119 12.1.2.2 FUNGI AND YEAST BASED 119 12.1.3 LAYERS 119 12.1.3.1 BACTERIA BASED 120 12.1.3.2 FUNGI AND YEAST BASED 120 12.1.4 BREEDERS 120 12.1.4.1 BACTERIA BASED 121 12.1.4.2 FUNGI AND YEAST BASED 121 12.1.5 OTHERS 121 13 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY REGION 122 13.1 MIDDLE EAST AND AFRICA 123 13.1.1 SOUTH AFRICA 134 13.1.2 SAUDI ARABIA 141 13.1.3 KUWAIT 148 13.1.4 U.A.E. 155 13.1.5 REST OF MIDDLE EAST AND AFRICA 161 14 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET: COMPANY LANDSCAPE 162 14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 162 15 SWOT ANALYSIS 163 16 COMPANY PROFILE 164 16.1 LALLEMAND INC 164 16.1.1 COMPANY SNAPSHOT 164 16.1.2 COMPANY SHARE ANALYSIS 164 16.1.3 PRODUCT PORTFOLIO 165 16.1.4 RECENT DEVELOPMENT 165 16.2 EVONIK INDUSTRIES AG 166 16.2.1 COMPANY SNAPSHOT 166 16.2.2 REVENUE ANALYSIS 166 16.2.3 COMPANY SHARE ANALYSIS 167 16.2.4 PRODUCT PORTFOLIO 167 16.2.5 RECENT DEVELOPMENT 167 16.3 ASAHI GROUP HOLDINGS, LTD 168 16.3.1 COMPANY SNAPSHOT 168 16.3.2 REVENUE ANALYSIS 168 16.3.3 COMPANY SHARE ANALYSIS 169 16.3.4 PRODUCT PORTFOLIO 169 16.3.5 RECENT DEVELOPMENT 169 16.4 INTERNATIONAL FLAVORS & FRAGRANCES INC 170 16.4.1 COMPANY SNAPSHOT 170 16.4.2 REVENUE ANALYSIS 170 16.4.3 COMPANY SHARE ANALYSIS 171 16.4.4 PRODUCT PORTFOLIO 171 16.4.5 RECENT DEVELOPMENT 171 16.5 PHILEO BY LESAFFRE 172 16.5.1 COMPANY SNAPSHOT 172 16.5.2 COMPANY SHARE ANALYSIS 172 16.5.3 PRODUCT PORTFOLIO 173 16.5.4 RECENT DEVELOPMENT 173 16.6 ADVANCED ENZYME TECHNOLOGIES 174 16.6.1 COMPANY SNAPSHOT 174 16.6.2 REVENUE ANALYSIS 174 16.6.3 PRODUCT PORTFOLIO 175 16.6.4 RECENT DEVELOPMENT 175 16.7 ALLTECH 176 16.7.1 COMPANY SNAPSHOT 176 16.7.2 PRODUCT PORTFOLIO 176 16.7.3 RECENT DEVELOPMENTS 176 16.8 BIOCAMP 177 16.8.1 COMPANY SNAPSHOT 177 16.8.2 PRODUCT PORTFOLIO 177 16.8.3 RECENT DEVELOPMENT 177 16.9 CHR. HANSEN HOLDING A/S 178 16.9.1 COMPANY SNAPSHOT 178 16.9.2 REVENUE ANALYSIS 178 16.9.3 PRODUCT PORTFOLIO 179 16.9.4 RECENT DEVELOPMENT 179 16.10 INTERNATIONAL ANIMAL HEALTH PRODUCTS 180 16.10.1 COMPANY SNAPSHOT 180 16.10.2 PRODUCT PORTFOLIO 180 16.10.3 RECENT DEVELOPMENT 180 16.11 KEMIN INDUSTRIES, INC 181 16.11.1 COMPANY SNAPSHOT 181 16.11.2 PRODUCT PORTFOLIO 181 16.11.3 RECENT DEVELOPMENT 181 16.12 NOVOZYMES 182 16.12.1 COMPANY SNAPSHOT 182 16.12.2 REVENUE ANALYSIS 182 16.12.3 PRODUCT PORTFOLIO 183 16.12.4 RECENT DEVELOPMENT 183 16.13 PANGOO 184 16.13.1 COMPANY SNAPSHOT 184 16.13.2 PRODUCT PORTFOLIO 184 16.13.3 RECENT DEVELOPMENT 184 16.14 PROVITA ANIMAL HEALTH 185 16.14.1 COMPANY SNAPSHOT 185 16.14.2 PRODUCT PORTFOLIO 185 16.14.3 RECENT DEVELOPMENT 185 16.15 UNIQUE BIOTECH 186 16.15.1 COMPANY SNAPSHOT 186 16.15.2 PRODUCT PORTFOLIO 186 16.15.3 RECENT DEVELOPMENT 186 17 QUESTIONNAIRE 187 18 RELATED REPORTS 190
SummaryThe Middle East and Africa poultry probiotic ingredients market is expected to reach USD 88,346.43 thousand by 2030 from USD 61,730.85 thousand in 2022, growing at a CAGR of 4.7% during the forecast period of 2023 to 2030. Table of ContentsTABLE OF CONTENTS1 INTRODUCTION 42 1.1 OBJECTIVES OF THE STUDY 42 1.2 MARKET DEFINITION 42 1.3 OVERVIEW OF MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET 42 1.4 LIMITATIONS 44 1.5 MARKETS COVERED 44 2 MARKET SEGMENTATION 47 2.1 MARKETS COVERED 47 2.2 GEOGRAPHICAL SCOPE 48 2.3 YEARS CONSIDERED FOR THE STUDY 49 2.4 CURRENCY AND PRICING 49 2.5 DBMR TRIPOD DATA VALIDATION MODEL 50 2.6 MULTIVARIATE MODELLING 53 2.7 PRODUCT LIFELINE CURVE 53 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 54 2.9 DBMR MARKET POSITION GRID 55 2.10 MARKET END USERS COVERAGE GRID 56 2.11 VENDOR SHARE ANALYSIS 57 2.12 SECONDARY SOURCES 58 2.13 ASSUMPTIONS 58 3 EXECUTIVE SUMMARY 59 4 PREMIUM INSIGHTS 61 4.1 VALUE CHAIN ANALYSIS 62 4.2 SUPPLY CHAIN ANALYSIS 63 4.2.1 RAW MATERIAL PROCUREMENT 63 4.2.2 MANUFACTURING AND DISTRIBUTION 63 4.2.3 END USERS 63 4.3 PORTER'S FIVE FORCES 64 4.3.1 BARGAINING POWER OF SUPPLIERS 64 4.3.2 BARGAINING POWER OF BUYERS/CONSUMERS 64 4.3.3 THREAT OF NEW ENTRANTS 65 4.3.4 THREAT OF SUBSTITUTES PRODUCTS 65 4.3.5 INTENSITY OF COMPETITIVE RIVALRY 65 4.4 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 66 4.5 OVERVIEW OF TECHNOLOGICAL INNOVATIONS 67 4.6 INDUSTRY TRENDS AND FUTURE PERSPECTIVE 68 4.7 FACTORS INFLUENCING PURCHASING DECISION OF END-USERS 69 5 PRICING ANALYSIS 70 6 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, REGULATIONS 71 7 MARKET OVERVIEW, MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET 73 7.1 DRIVERS 75 7.1.1 GROWING PRODUCTION OF FEED ADDITIVES 75 7.1.2 INCREASING AWARENESS OF THE BENEFITS OF PLANT-BASED PRODUCTS 75 7.1.3 INCREASED DEMAND AND CONSUMPTION OF LIVESTOCK-BASED PRODUCTS 76 7.2 RESTRAINTS 76 7.2.1 STRICT RESTRICTIONS AND REGULATIONS IMPOSED BY GOVERNMENT 76 7.2.2 INADEQUATE RAW MATERIAL AVAILABILITY 77 7.3 OPPORTUNITIES 77 7.3.1 GROWING COMMERCIAL APPLICATION 77 7.3.2 RISING RESEARCH AND DEVELOPMENT ACTIVITIES 77 7.4 CHALLENGES 78 7.4.1 AVAILABILITY OF FEED ADDITIVE SUBSTITUTES 78 7.4.2 PRODUCT LABELLING AND TRADE ISSUES 78 8 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY PRODUCT 79 8.1 OVERVIEW 80 8.1.1 BACTERIA BASED 83 8.1.1.1 BACILLUS 84 8.1.1.1.1 SUBTILIS 85 8.1.1.1.2 LICHENIFORMIS 85 8.1.1.1.3 AMYLOLIQUEFACIENS 85 8.1.1.1.4 MEGATERIUM 85 8.1.1.1.5 MESENTRICUS 85 8.1.1.1.6 POLYMYXA 85 8.1.1.1.7 TOYONENSIS 85 8.1.1.1.8 OTHERS 85 8.1.1.2 LACTOBACILLUS 86 8.1.1.2.1 ACIDOPHILUS 86 8.1.1.2.2 BULGARICUS 86 8.1.1.2.3 REUTERI 86 8.1.1.2.4 CASEI 87 8.1.1.2.5 LACTIS 87 8.1.1.2.6 SALIVARIUS 87 8.1.1.2.7 PLANTARUM 87 8.1.1.2.8 RHAMNOSUS 87 8.1.1.2.9 FERMENTUM 87 8.1.1.2.10 FARCIMINIS 87 8.1.1.2.11 THERMOPHILUS 87 8.1.1.2.12 OTHERS 88 8.1.1.3 BIFIDOBACTERIUM 88 8.1.1.3.1 BIFIDIUM 88 8.1.1.3.2 BIFIDUS 88 8.1.1.3.3 THERMOPHILUS 88 8.1.1.3.4 ANIMALS 88 8.1.1.3.5 OTHERS 89 8.1.1.4 ENTEROCOCCUS 89 8.1.1.5 STREPTOCOCCUS 89 8.1.1.6 CLOSTRIDIUM 89 8.1.1.7 PEDIOCOCCUS 89 8.1.1.7.1 PARVULUS 89 8.1.1.7.2 ACIDILACTICI 89 8.1.1.7.3 OTHERS 90 8.1.2 FUNGI AND YEAST BASED 90 8.1.2.1 SACCHAROMYCES CEREVISIAE 91 8.1.2.2 SACCHAROMYCES BOULARDII 91 8.1.2.3 SACCHAROMYCES SERVISIA 91 8.1.2.4 CANDIDA 91 9 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY TYPE 92 9.1 OVERVIEW 93 9.1.1 SINGLE STRAIN 96 9.1.2 MULTIPLE STRAIN 96 10 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY FORM 98 10.1 OVERVIEW 99 10.1.1 DRY 102 10.1.2 LIQUID 102 11 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY FUNCTION 104 11.1 OVERVIEW 105 11.1.1 GUT HEALTH 108 11.1.2 IMMUNITY 108 11.1.3 NUTRITION 109 11.1.4 FEED INTAKE AND EFFICIENCY 110 11.1.5 YIELD 110 11.1.6 EGG PRODUCTION AND QUALITY 111 11.1.7 OTHERS 112 12 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY APPLICATION 113 12.1 OVERVIEW 114 12.1.1 CHICKS AND POULTS 117 12.1.1.1 BACTERIA BASED 118 12.1.1.2 FUNGI AND YEAST BASED 118 12.1.2 BROILERS 118 12.1.2.1 BACTERIA BASED 119 12.1.2.2 FUNGI AND YEAST BASED 119 12.1.3 LAYERS 119 12.1.3.1 BACTERIA BASED 120 12.1.3.2 FUNGI AND YEAST BASED 120 12.1.4 BREEDERS 120 12.1.4.1 BACTERIA BASED 121 12.1.4.2 FUNGI AND YEAST BASED 121 12.1.5 OTHERS 121 13 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET, BY REGION 122 13.1 MIDDLE EAST AND AFRICA 123 13.1.1 SOUTH AFRICA 134 13.1.2 SAUDI ARABIA 141 13.1.3 KUWAIT 148 13.1.4 U.A.E. 155 13.1.5 REST OF MIDDLE EAST AND AFRICA 161 14 MIDDLE EAST & AFRICA POULTRY PROBIOTIC INGREDIENTS MARKET: COMPANY LANDSCAPE 162 14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 162 15 SWOT ANALYSIS 163 16 COMPANY PROFILE 164 16.1 LALLEMAND INC 164 16.1.1 COMPANY SNAPSHOT 164 16.1.2 COMPANY SHARE ANALYSIS 164 16.1.3 PRODUCT PORTFOLIO 165 16.1.4 RECENT DEVELOPMENT 165 16.2 EVONIK INDUSTRIES AG 166 16.2.1 COMPANY SNAPSHOT 166 16.2.2 REVENUE ANALYSIS 166 16.2.3 COMPANY SHARE ANALYSIS 167 16.2.4 PRODUCT PORTFOLIO 167 16.2.5 RECENT DEVELOPMENT 167 16.3 ASAHI GROUP HOLDINGS, LTD 168 16.3.1 COMPANY SNAPSHOT 168 16.3.2 REVENUE ANALYSIS 168 16.3.3 COMPANY SHARE ANALYSIS 169 16.3.4 PRODUCT PORTFOLIO 169 16.3.5 RECENT DEVELOPMENT 169 16.4 INTERNATIONAL FLAVORS & FRAGRANCES INC 170 16.4.1 COMPANY SNAPSHOT 170 16.4.2 REVENUE ANALYSIS 170 16.4.3 COMPANY SHARE ANALYSIS 171 16.4.4 PRODUCT PORTFOLIO 171 16.4.5 RECENT DEVELOPMENT 171 16.5 PHILEO BY LESAFFRE 172 16.5.1 COMPANY SNAPSHOT 172 16.5.2 COMPANY SHARE ANALYSIS 172 16.5.3 PRODUCT PORTFOLIO 173 16.5.4 RECENT DEVELOPMENT 173 16.6 ADVANCED ENZYME TECHNOLOGIES 174 16.6.1 COMPANY SNAPSHOT 174 16.6.2 REVENUE ANALYSIS 174 16.6.3 PRODUCT PORTFOLIO 175 16.6.4 RECENT DEVELOPMENT 175 16.7 ALLTECH 176 16.7.1 COMPANY SNAPSHOT 176 16.7.2 PRODUCT PORTFOLIO 176 16.7.3 RECENT DEVELOPMENTS 176 16.8 BIOCAMP 177 16.8.1 COMPANY SNAPSHOT 177 16.8.2 PRODUCT PORTFOLIO 177 16.8.3 RECENT DEVELOPMENT 177 16.9 CHR. HANSEN HOLDING A/S 178 16.9.1 COMPANY SNAPSHOT 178 16.9.2 REVENUE ANALYSIS 178 16.9.3 PRODUCT PORTFOLIO 179 16.9.4 RECENT DEVELOPMENT 179 16.10 INTERNATIONAL ANIMAL HEALTH PRODUCTS 180 16.10.1 COMPANY SNAPSHOT 180 16.10.2 PRODUCT PORTFOLIO 180 16.10.3 RECENT DEVELOPMENT 180 16.11 KEMIN INDUSTRIES, INC 181 16.11.1 COMPANY SNAPSHOT 181 16.11.2 PRODUCT PORTFOLIO 181 16.11.3 RECENT DEVELOPMENT 181 16.12 NOVOZYMES 182 16.12.1 COMPANY SNAPSHOT 182 16.12.2 REVENUE ANALYSIS 182 16.12.3 PRODUCT PORTFOLIO 183 16.12.4 RECENT DEVELOPMENT 183 16.13 PANGOO 184 16.13.1 COMPANY SNAPSHOT 184 16.13.2 PRODUCT PORTFOLIO 184 16.13.3 RECENT DEVELOPMENT 184 16.14 PROVITA ANIMAL HEALTH 185 16.14.1 COMPANY SNAPSHOT 185 16.14.2 PRODUCT PORTFOLIO 185 16.14.3 RECENT DEVELOPMENT 185 16.15 UNIQUE BIOTECH 186 16.15.1 COMPANY SNAPSHOT 186 16.15.2 PRODUCT PORTFOLIO 186 16.15.3 RECENT DEVELOPMENT 186 17 QUESTIONNAIRE 187 18 RELATED REPORTS 190
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(食品)の最新刊レポートData Bridge Market Research社の食品・飲料分野での最新刊レポート
本レポートと同じKEY WORD(probiotic)の最新刊レポートよくあるご質問Data Bridge Market Research社はどのような調査会社ですか?データブリッジマーケットリサーチ(Data Bridge Market Research)は500名以上の多様な分野のアナリストが所属するインドの調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |